Cannabis Revenue Pressure, Medical Evidence and L.A. Fire Risk

Illinois cannabis sales data underscores intensifying price compression, while new cancer-patient research highlights demand for stronger clinical evidence. Near Los Angeles, firefighters gained ground on a fast-moving Santa Clarita wildfire after evacuations.

Cannabis Ballot Risk Rises as AI Tensions Hit Hollywood

Massachusetts voters confront a potentially historic cannabis rollback, High Tide expands its Canadian retail footprint, and Nicolas Cage’s dispute with Amazon puts Hollywood’s AI consent battle back in focus.

Cannabis Court Fight Advances as Bedrocan Enters Bankruptcy

Federal cannabis opponents and the Justice Department proposed a timetable for a major rescheduling lawsuit, while the Netherlands’ sole medical cannabis supplier entered bankruptcy. Netflix is also reportedly preparing its largest workforce reduction since 2022.

Cannabis Strategy Shifts While Spotify Locks In Rogan

Tilray’s record revenue highlighted the growing role of beverages in cannabis-company diversification, while Washington regulators advanced a potentially important bridge between state licensing and federal requirements. Spotify also secured its flagship podcast relationship with a new multiyear Joe Rogan agreement.

DEA Opens Cannabis Registration as Medicare Hemp Fight Escalates

Federal cannabis policy moved deeper into implementation as the DEA opened specialized registration channels for medical marijuana businesses and opponents escalated a challenge to a Medicare hemp initiative. In Hollywood, Paramount completed its Warner Bros. Discovery acquisition, formally creating Skydance.